These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 26685760)
1. Elevations in C-reactive protein and endothelin-1 system activity in humans. Dow CA; Templeton DL; Lincenberg GM; Greiner JJ; Stauffer BL; DeSouza CA Life Sci; 2016 Aug; 159():66-70. PubMed ID: 26685760 [TBL] [Abstract][Full Text] [Related]
2. Impaired fasting blood glucose is associated with increased endothelin-1 vasoconstrictor tone. Diehl KJ; Templeton DL; Ma J; Weil BR; Greiner JJ; Stauffer BL; DeSouza CA Atherosclerosis; 2013 Jul; 229(1):130-3. PubMed ID: 23643051 [TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and endothelin-1 mediated vasoconstrictor tone in overweight/obese adults. Rocha NG; Templeton DL; Greiner JJ; Stauffer BL; DeSouza CA Metabolism; 2014 Jul; 63(7):951-6. PubMed ID: 24856242 [TBL] [Abstract][Full Text] [Related]
4. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects. Wimalasundera RC; McG Thom SA; Regan L; Hughes AD Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621 [TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilatation in men. Westby CM; Weil BR; Greiner JJ; Stauffer BL; DeSouza CA Clin Sci (Lond); 2011 Jun; 120(11):485-91. PubMed ID: 21143196 [TBL] [Abstract][Full Text] [Related]
6. White blood cell count and endothelin-1 vasoconstrictor tone in middle-aged and older adults. Diehl KJ; Weil BR; Greiner JJ; Stauffer BL; Desouza CA Artery Res; 2012 Jun; 6(2):65-70. PubMed ID: 23908675 [TBL] [Abstract][Full Text] [Related]
7. ENDOTHELIN-1 SYTEM ACTIVITY IN ADULTS WITH BORDERLINE HIGH LDL-CHOLESTEROL. Diehl KJ; Stauffer BL; Greiner JJ; DeSouza CA Artery Res; 2014 Sep; 8(3):115-118. PubMed ID: 25267931 [TBL] [Abstract][Full Text] [Related]
8. Short sleep duration is associated with enhanced endothelin-1 vasoconstrictor tone. Weil BR; Mestek ML; Westby CM; Van Guilder GP; Greiner JJ; Stauffer BL; DeSouza CA Can J Physiol Pharmacol; 2010 Aug; 88(8):777-81. PubMed ID: 20725134 [TBL] [Abstract][Full Text] [Related]
9. The vascular endothelin system is not overactive in normotensive hemodialysis patients. Büssemaker E; Passauer J; Reimann D; Schulze B; Reichel W; Gross P Kidney Int; 2002 Sep; 62(3):940-8. PubMed ID: 12164876 [TBL] [Abstract][Full Text] [Related]
10. Chronic Nebivolol Treatment Suppresses Endothelin-1-Mediated Vasoconstrictor Tone in Adults With Elevated Blood Pressure. Diehl KJ; Stauffer BL; Dow CA; Bammert TD; Brunjes DL; Greiner JJ; DeSouza CA Hypertension; 2016 Jun; 67(6):1196-204. PubMed ID: 27113048 [TBL] [Abstract][Full Text] [Related]
11. Reduced endothelin-1- and nitric oxide-mediated arteriolar tone in hypertensive renal transplant recipients. Passauer J; Lässig G; Büssemaker E; Pistrosch F; Gross P Kidney Int; 2004 May; 65(5):1782-9. PubMed ID: 15086917 [TBL] [Abstract][Full Text] [Related]
12. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis. Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846 [TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Van Guilder GP; Westby CM; Greiner JJ; Stauffer BL; DeSouza CA Hypertension; 2007 Aug; 50(2):403-9. PubMed ID: 17576858 [TBL] [Abstract][Full Text] [Related]
14. Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients. Cardillo C; Campia U; Iantorno M; Panza JA Hypertension; 2004 Jan; 43(1):36-40. PubMed ID: 14656951 [TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 and vascular tone in subjects with atherogenic risk factors. Nohria A; Garrett L; Johnson W; Kinlay S; Ganz P; Creager MA Hypertension; 2003 Jul; 42(1):43-8. PubMed ID: 12756218 [TBL] [Abstract][Full Text] [Related]
16. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120 [TBL] [Abstract][Full Text] [Related]
17. Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis. Cardillo C; Schinzari F; Melina D; Mores N; Bosello S; Peluso G; Zoli A; Ferraccioli G Arthritis Rheum; 2009 Jun; 60(6):1840-4. PubMed ID: 19479828 [TBL] [Abstract][Full Text] [Related]
18. Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome. Schinzari F; Tesauro M; Rovella V; Di Daniele N; Mores N; Veneziani A; Cardillo C J Clin Endocrinol Metab; 2013 Mar; 98(3):1235-41. PubMed ID: 23372172 [TBL] [Abstract][Full Text] [Related]
19. Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure. Hand MF; Haynes WG; Webb DJ Kidney Int; 1999 Feb; 55(2):613-20. PubMed ID: 9987085 [TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis. Böhm F; Ahlborg G; Pernow J Clin Sci (Lond); 2002 Mar; 102(3):321-7. PubMed ID: 11869173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]